Prognostic significance of tumor markers in T4a gastric cancer

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Liu, Xiaowen ^a   Cai, Hong ^a   Wang, Yanong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Gastric cancer; Prognosis; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CAMPTOTHECIN; CANCER ANTIGEN 50; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; DOXIFLURIDINE; FLUOROURACIL; MITOMYCIN C; TEGAFUR; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GASTRECTOMY; HUMAN; HUMAN CELL; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PREOPERATIVE PERIOD; STOMACH CANCER;

ADENOCARCINOMA; ALPHA-FETOPROTEINS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862208107     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-68     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
2. McCulloch P, Taggart T, Ochiai A, O'Dowd G, Nash J, Sasako M. c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. Eur J Surg Oncol 1997, 23:304-309. 10.1016/S0748-7983(97)90669-7, 9315057.
3. Livingstone JI, Yasui W, Tahara E, Wastell C. Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study. Br J Cancer 1995, 72:976-980. 10.1038/bjc.1995.445, 2034064, 7547252.
4. Gill S, Shah A, Le N, Cook EF, Yoshida EM. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a Canadian cancer center. J Clin Oncol 2003, 21:2070-2076. 10.1200/JCO.2003.11.054, 12775731.
5. Chau I, Norman AR, Cunningham D, Waters JS, Oates J, Ross PJ. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 2004, 22:2395-2403. 10.1200/JCO.2004.08.154, 15197201.
6. Yokota T, Ishiyama S, Saito T, Teshima S, Narushima Y, Murata K, Yashima R, Yamauchi H, Kikuchi S. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol 2004, 39:380-384. 10.1080/00365520310008629, 15125471.
7. Dicken BJ, Saunders LD, Jhangri GS, de Gara C, Cass C, Andrews S, Hamilton SM. Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Ann Surg Oncol 2004, 11:629-635. 10.1245/ASO.2004.09.002, 15150070.
8. Ychou M, Duffour J, Kramar A, Gourgou S, Grenier J. Clinical significance and prognostic value of CA 72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis Markers 2000, 16:105-110.
9. Gao ZL, Zhang C, Du GY, Lu ZJ. Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma. Hepatogastroenterology 2007, 54:1591-1595.
10. Adachi Y, Tsuchihashi J, Shiraishi N, Yasuda K, Etoh T, Kitano S. AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncology 2003, 65:95-101. 10.1159/000072332, 12931013.
11. Abelev GI, Perova SD, Khramkova NI, Postnikova ZA, Irlin IS. Production of embryonal alpha-globulin by transplantable mouse hepatomas. Transplantation 1963, 1:174-180. 10.1097/00007890-196301020-00004, 14010646.
12. Ishigami S, Natsugoe S, Nakashima H, Tokuda K, Nakajo A, Okumura H, Matsumoto M, Nakashima S, Hokita S, Aikou T. Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. Hepatogastroenterology 2006, 53:338-341.
13. Chang YC, Nagasue N, Kohno H, Taniura H, Uchida M, Yamanoi A, Kimoto T, Nakamura T. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. Am J Gastroenterol 1990, 85:1480-1485.
14. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965, 122:467-481. 10.1084/jem.122.3.467, 2138078, 4953873.
15. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genetics 1979, 5:957-971. 10.1007/BF01542654, 94699.
16. Holmgren J, Lindholm L, Persson B, Lagergård T, Nilsson O, Svennerholm L, Rudenstam CM, Unsgaard B, Yngvason F, Pettersson S, Killander AF. Detection by monoclonal antibody of carbohydrate antigen CA-50 in serum of patient with carcinoma. Br Med J 1984, 288:1479-1482.
17. Sobin LH, Gospodarowicz MK, Wittekind C. International Union Against Cancer (UICC) TNM classification of malignant tumours 2010, Wiley-Liss, New York, 7.
18. Japanese Gastric Cancer Association Japanese classification of gastric cancer, 2nd English edition. Gastric Cancer 1998, 1:10-24. Japanese Gastric Cancer Association.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
20. Cox DR. Regression models and life-tables. J R Stat Soc B 1972, 34:187-220.
21. Grem J. The prognostic importance of tumor markers in adenocarcinomas of the gastrointestinal tract. Curr Opin Oncol 1997, 9:380-387. 10.1097/00001622-199709040-00012, 9251889.
22. Webb A, Scott-Mackie P, Cunningham D, Norman A, Andreyev J, O'Brien M, Bensted J. The prognostic value of serum and immunohistochemical tumor markers in advanced gastric cancer. Eur J Cancer 1996, 32A:63-68.
23. Ikeda Y, Oomori H, Koyanagi N, Mori M, Kamakura T, Minagawa S, Tateishi H, Sugimachi K. Prognostic value of combination assays for CEA and CA19-9 in gastric cancer. Oncology 1995, 52:483-486. 10.1159/000227515, 7478435.
24. Nakajima K, Ochiai T, Suzuki T, Shimada H, Hayashi H, Yasumoto A, Takeda A, Hishikawa E, Isono K. Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients. Tumour Biol 1998, 19:464-469. 10.1159/000030038, 9817974.
25. Kochi M, Fujii M, Kanamori N, Kaiga T, Kawakami T, Aizaki K, Kasahara M, Mochizuki F, Kasakura Y, Yamagata M. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer 2000, 3:177-186. 10.1007/PL00011715, 11984734.
26. Ucar E, Semerci E, Ustun H, Yetim T, Huzmeli C, Gullu M. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther 2008, 25:1075-1084. 10.1007/s12325-008-0100-4, 18821070.
27. Duraker N, Celik AN. The prognostic significance of preoperative serum CA19-9 in patients with respectable gastric carcinoma: comparison with CEA. J Surg Oncol 2001, 76:266-271. 10.1002/jso.1044, 11320518.
28. Carpelan-HolmstrÖm M, Louhimo J, Stenman UH, Alfthan H, Haglund C. CEA, CA 19-9 and CA72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 2002, 22:2311-2316.
29. Gaspar MJ, Arribas I, Coca MC, Díez-Alonso M. Prognostic value of carcinoembryonic antigen, CA19-9 and CA72-4 in gastric carcinoma. Tumour Biol 2001, 22:318-322. 10.1159/000050633, 11553862.
30. Tocchi A, Costa G, Lepre L, Liotta G, Mazzoni G, Cianetti A, Vannini P. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. J Cancer Res Clin Oncol 1998, 124:450-455. 10.1007/s004320050198, 9750022.
31. Ikeda Y, Mori M, Kajiyama K, Kamakura T, Maehara Y, Haraguchi Y, Sugimachi K. Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer. Hepatogastroenterology 1996, 43:1281-1287.
32. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer-a survey. Biochim Biophys Acta 2007, 1775:181-232.
33. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang C-Y. Characterization of MicroRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other disease. Cell Res 2008, 18:997-1006. 10.1038/cr.2008.282, 18766170.